| Whitney A Fields, PHARMD | |
|
25 Nichols Dr, Barboursville, WV 25504-1813 | |
| (203) 733-6188 | |
| Not Available |
| Full Name | Whitney A Fields |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 25 Nichols Dr, Barboursville, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235730599 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0012173 (West Virginia) | Primary |
| 183500000X | Pharmacist | 021656 (Kentucky) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Whitney A Fields, PHARMD Po Box 212, Hartford, WV 25247-0212 Ph: (304) 674-6630 | Whitney A Fields, PHARMD 25 Nichols Dr, Barboursville, WV 25504-1813 Ph: (203) 733-6188 |
News Archive
Low doses of the environmental contaminant bisphenol–A (BPA), widely used to make many plastics found in food storage containers, including feeding bottles for infants, can impair brain function, leading to learning disabilities and age–related neurodegenerative diseases, according to Yale researchers and colleagues.
Oncotarget recently published "Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer" which reported that the authors investigated whether Trop-2-expression and homologous recombination repair of SN-38-mediated double-strand DNA breaks play a role in the sensitivity of triple-negative breast cancer to SG.
Progenics Pharmaceuticals, Inc. today announced the presentation of preclinical data on novel monoclonal antibodies against toxins produced by the bacterium Clostridium difficile (C. difficile). The monoclonal antibodies effectively neutralized the cell-killing activities of the toxins in vitro and significantly improved survival in a stringent animal model of C. difficile infection. C. difficile is the leading cause of hospital-acquired diarrhea in the United States and represents a growing global public health challenge.
Most Californians find gun safety conversations that take place in the exam room appropriate if a patient has access to a gun and the patient - or someone in the patient's home - is at increased risk for firearm-related harm, such as trouble with drugs or alcohol misuse.
The U.S. Food and Drug Administration today announced labeling changes, including a Boxed Warning, to highlight the risks of life-threatening infections, including progressive multifocal leukoencephalopathy (PML), with the use of Raptiva (efalizumab). The labeling changes are based on the FDA's post-market surveillance.
› Verified 4 days ago
Erin Marcum, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6414 Us Route 60 E, Barboursville, WV 25504 Phone: 304-736-0528 | |
Clayton Andrew Lightner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6414 Us Route 60 E, Barboursville, WV 25504 Phone: 304-736-0528 | |
Joseph Hovious, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2070 Thundering Herd Dr, T-1478, Barboursville, WV 25504 Phone: 304-736-7651 Fax: 304-736-7651 | |
Ryan Young, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6350 Us Route 60 East, Barboursville, WV 25504 Phone: 304-948-6651 | |
Holly Poe, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6414 Us Route 60 E, Barboursville, WV 25504 Phone: 304-736-0528 | |
John Petts, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6414 Us Route 60 E, Barboursville, WV 25504 Phone: 304-736-0528 Fax: 304-736-0960 |